People

Jorge Conde

Jorge Conde

General Partner at Andreessen Horowitz

Menlo Park, California

linkedin.comtwitter.comsignal.nfx.com

General Partner at Andreessen Horowitz

Current affiliation
Andreessen Horowitz · General Partner
Investment range
$1M – $100M
Sweet spot
$10M
Investments on record
40

Investments

$52M2026-02-04Third Arc BioJorge Conde
$14M2026-02-03PhyloJorge Conde
$14M2026-02PhyloJorge Conde
$52M2026-02Third Arc BioJorge Conde
$210M2023-12-12Tome BiosciencesJorge Conde
$210M2023-12Tome BiosciencesJay Markowitz, Jorge Conde
$180M2023-01-05AsimovVijay Pande, Jorge Conde
$180M2023-01AsimovJorge Conde
$65M2022-07-28Vicinitas TherapeuticsJorge Conde
$100M2022-07-20CAMP4 TherapeuticsJorge Conde

Roles

Andreessen Horowitz

General Partner

Current
Flagship Pioneering

Life Sciences Summer Associate

Current
Morgan Stanley

Biotechnology Investment Banking

Current
Dyno Therapeutics

Board Member

Current
Knome Inc.

Co-Founder and CEO | Board of Directors

Current
Syros Pharmaceuticals

Chief Strategy Officer | Chief Financial Officer | Chief Product Officer

Current
MedImmune

Marketing & Operations Manager

Current
Current
Current
EQRx

Board Member

Current
CAMP4 Therapeutics

Board Member

Current
Tome Biosciences

Board Member

Current
IDRx

Board Member

Current
Earli

Board Member

Current
Octant

Board Member

Current
Komodo Health

Board Member

Current
Current
Current
Asimov

Board Member

Current
Andreessen Horowitz

general_partner

Current